Watch CBS News

FDA fast-tracks approval for Alzheimer's drug

Name: FDA fast-tracks approval for Alzheimer's drug
Uploaded: 2023-01-06T18:48:11-0500
Duration: 23 s
Description: The Food and Drug Administration approved a new Alzheimer's drug called Leqembi, that has been shown to slow the decline in memory and thinking. The medication costs more than $26,000 per year.

The Food and Drug Administration approved a new Alzheimer's drug called Leqembi, that has been shown to slow the decline in memory and thinking. The medication costs more than $26,000 per year.